Institut Cancerologie de l'Ouest

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

4 drugs in development

Approved1

Phase 11

Preclinical3

By Therapeutic Area

top 2

Oncology

480%

Musculoskeletal

120%

R&D Momentum

52/100

Pipeline Velocity

19/100

Trial Completion Rate

76/100

Pipeline Concentration

68/100

Pipeline Freshness

44/100

Strategic Signals

↗Early-stage heavy pipeline may seek late-stage partners
↗Active in Musculoskeletal but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Nov 5, 2026

Recruiting

To Assess the Contribution of Sophrology Assisted by an Ambulatory Device on the Anxiety of Patients Undergoing Chemotherapy for the Treatment of Localized Breast Cancer.

Oct 31, 2026

Completed

Patient Over 75 Years With Prostate Cancer: Geriatric Determinants of General Repercussion of Radiotherapy With Curative Intent

Oct 31, 2026

Completed

CLINICAL MULTICENTER STUDY OF PHASE II Hypofractionated Stereotactic Radiotherapy With Irinotecan IN THE TREATMENT OF LIVER METASTASIS AND / OR PULMONARY, Unoperated or Recurrent After Surgery of a Colorectal Cancer

Earlier

Sep 1, 2026TrialRandomized Controlled Trial Evaluating the Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

Aug 18, 2026TrialInvestigating the Value of Reticulocyte Haemoglobin Content (RET-he) in the Management of Functional Martial Deficiency Anaemia in Patients With Solid Tumours

Aug 13, 2026TrialMinimal Harvest Dorsalis Major Flap Breast Reconstruction: Retrospective and Prospective Evaluation of Scapulohumeral Comfort, Aesthetic Result and Quality of Life

Aug 8, 2026TrialPilot Study in Cancer Patients Scheduled for Surgery Evaluating Different Smoking Cessation Protocols : Nicotine Replacement (NRT), Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy

Jul 21, 2026TrialProspective Phase II Pilot Study, Assessing Imaging Performance of 89Zirconium-labelled Girentuximab (89Zr-TLX250) PET-CT (Positron Emission Tomography/Computerized Tomography) in Metastatic Triple Negative Breast Cancer Patients

2 more events

Jul 3, 2026TrialMedico-economic Evaluation Comparing Radiotherapy With Intensity Modulation (IMRT) Performed by, Helical Tomotherapy: Hi Art and Dynamic Arc Therapy: RapidArc, VMAT in Cancers With Pelvic Lymph Node Irradiation: Prostate, Cervix, Anal Canal

Jul 2, 2026TrialA Randomized, Double Blind, Controlled, Multi-center, Phase III Study to Assess Efficacy of Low Level Diode Laser (100 MW, 658 Nm), in the Prevention and Treatment of Radiochemotherapy-induced Mucositis in Head and Neck Cancer.

Details